We are live on
!
Find out more
IAM
Innovis Asset Management Portfolio holdings
AUM
$260M
1-Year Est. Return
28.13%
This Fund
S&P 500
This Quarter
Est. Return
-2.3%
1 Year Est. Return
+28.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$260M
AUM Growth
-$11.2M
(-4.1%)
Cap. Flow
-$31.8K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
35.09%
Holding
186
New
24
Increased
65
Reduced
40
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.74M |
| 2 |
CrowdStrike
CRWD
|
+$3.61M |
| 3 |
Microsoft
MSFT
|
+$3.54M |
| 4 |
Boeing
BA
|
+$3.39M |
| 5 |
Tesla
TSLA
|
+$2.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$4.8M |
| 2 |
Starbucks
SBUX
|
+$4.25M |
| 3 |
Performance Food Group
PFGC
|
+$3.22M |
| 4 |
Coca-Cola
KO
|
+$2.59M |
| 5 |
P
Everpure Inc
P
|
+$2.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 20.01% |
| 3 | Financials | 9.68% |
| 4 | Energy | 8.3% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
SolarEdge
SEDG
$1.93B
| – | – |
-7,993
| Closed | -$2.15M |
|
|
SWTX
177
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-8,613
| Closed | -$226K |
|
178
Tarsus Pharmaceuticals
TARS
$3.15B
| – | – |
-13,141
| Closed | -$237K |
|
179
Trevi Therapeutics
TRVI
$2.39B
| – | – |
-43,232
| Closed | -$103K |
|
180
Vera Therapeutics
VERA
$2.46B
| – | – |
-21,673
| Closed | -$348K |
|
181
Verizon
VZ
$208B
| – | – |
-7,254
| Closed | -$270K |
|
182
Beyond Air
XAIR
$4.41M
| – | – |
-134
| Closed | -$229K |
|
|
PRFT
183
DELISTED
Perficient Inc
PRFT
| – | – |
-7,747
| Closed | -$646K |
|
|
QUOT
184
DELISTED
Quotient Technology Inc
QUOT
| – | – |
-154,116
| Closed | -$592K |
|
|
BKI
185
DELISTED
Black Knight, Inc. Common Stock
BKI
| – | – |
-5,007
| Closed | -$299K |
|
|
DICE
186
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| – | – |
-8,851
| Closed | -$411K |
|
Similar funds
RCGI
RBGI
AEPLI
PWM
T
SC
CA
W
Innovis Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Innovis Asset Management held 186 positions worth $260M, down 4.1% from $271M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Innovis Asset Management's Q3 2023 filing shows 24 new, 65 increased, 40 reduced and 33 closed positions. Its largest new stake was Boeing: 15,478 shares worth $2.97M. The largest sale was DexCom, an estimated $4.8M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Innovis Asset Management's largest Q3 2023 buy was Boeing: 15,478 shares worth $2.97M.
- Innovis Asset Management added most to Amazon in Q3 2023, an estimated $3.74M increase.
- Innovis Asset Management's biggest Q3 2023 reduction was Everpure Inc, cutting an estimated $2.58M.
- Innovis Asset Management fully exited DexCom in Q3 2023, selling an estimated $4.8M.
- Innovis Asset Management's ten largest holdings make up 35% of its $260M portfolio in Q3 2023.
- Innovis Asset Management opened 24 new positions and closed 33 in Q3 2023.
- Innovis Asset Management's portfolio value fell 4.1% quarter-over-quarter to $260M.
Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.